The morphology and phenotype of this cutaneous tumor were different from that of the breast carcinoma, which was strongly and diffusely estrogen receptor‐positive and had a HER2 3+ expression without SOX10 expression. The gene discussed is ERBB2; the disease is breast carcinoma.